Mucocutaneous leishmaniasis: Accuracy and molecular validation of noninvasive procedures in a L. (V.) braziliensis-endemic area

Diagnostic Microbiology and Infectious Disease

Volumn 79, Issue 4, 2014, Pages 413-418

  Gomes, Ciro M ^a   de Paula, Natália A ^b   Cesetti, Mariana V ^a   Roselino, Ana Maria ^c   Sampaio, Raimunda N R ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b Laboratory of Molecular Biology Division of Dermatology Clinical Hospital of Ribeirão Preto   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cutaneous; Diagnosis; Leishmaniasis; Mucocutaneous; Polymerase chain reaction; Saliva; Sensitivity and specificity

Indexed keywords

KINETOPLASTID DNA; PROTOZOAL DNA; UNCLASSIFIED DRUG; KINETOPLAST DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENDEMIC DISEASE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LEISHMANIA BRAZILIENSIS; LEISHMANIN SKIN TEST; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; NON INVASIVE PROCEDURE; NOSE SMEAR; ORAL FILTER PAPER IMPRINT; PARASITE EXAMINATION; PARASITOLOGY IMMUNOFLUORESCENCE ASSAY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; SKIN LEISHMANIASIS; VALIDATION PROCESS; VERY ELDERLY; CASE CONTROL STUDY; CLASSIFICATION; GENETICS; ISOLATION AND PURIFICATION; LEISHMANIA; LEISHMANIASIS, MUCOCUTANEOUS; MIDDLE AGED; PARASITOLOGY; PROCEDURES; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA, KINETOPLAST; FEMALE; HUMANS; LEISHMANIA; LEISHMANIASIS, MUCOCUTANEOUS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84904092977     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.05.002     Document Type: Article

References (38)

1. Al-Qahtani M.S., Malik N.W., Jamil S., Mekki T.E. Diagnostic dilemma of primary mucosal leishmaniasis. Saudi Med J 2012, 33(11):1234-1238.
2. Boggild A.K., Miranda-Verastegui C., Espinosa D. Evaluation of a microculture method for isolation of Leishmania parasites from cutaneous lesions of patients in Peru. J Clin Microbiol 2007, 45(11):3680-3684.
3. Boggild A.K., Valencia B.M., Espinosa D., Veland N., Ramos A.P., Arevalo J., et al. Detection and species identification of Leishmania DNA from filter paper lesion impressions for patients with American cutaneous leishmaniasis. Clin Infect Dis 2010, 50(1):e1-e6.
4. Boggild A.K., Ramos A.P., Valencia B.M., Veland N., Calderon F., Arevalo J., et al. Diagnostic performance of filter paper lesion impression PCR for secondarily infected ulcers and nonulcerative lesions caused by cutaneous leishmaniasis. J Clin Microbiol 2011, 49(3):1097-1100.
5. Boggild A.K., Valencia B.M., Veland N., Pilar Ramos A., Calderon F., Arevalo J., et al. Non-invasive cytology brush PCR diagnostic testing in mucosal leishmaniasis: superior performance to conventional biopsy with histopathology. PLoS ONE 2011, 6(10):1-6. e26395.
6. Brasil. Ministério da Saúde Secretaria de Vigilancia em Saude. Manual de Vigilancia da Leishmaniose Tegumentar Americana/Ministério da Saúde, Secretaria de Vigilância em Saúde 2007, Editora do Ministério da Saúde, Brasília, [Atual]. 2nd ed.
7. Brelaz-de-Castro M.C., de Almeida A.F., de Oliveira A.P., de Assis-Souza M., da Rocha L.F., Pereira V.R. Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure. Cell Immunol 2012, 279(2):180-186.
8. Combe B. Update on the use of etanercept across a spectrum of rheumatoid disorders. Biologics 2008, 2(2):165-173.
9. Corvalan F., Sampaio R., Brustoloni Y., Andreotti R., Lima Júnior M. DNA identification of Leishmania (Viannia) braziliensis in human saliva from a patient with American cutaneous leishmaniasis. J Venom Anim Toxins Incl Trop Dis 2011, 17(1):98-102.
10. Dalrymple J.M., Stamp L.K., O'Donnell J.L., Chapman P.T., Zhang M., Barclay M.L. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 2008, 58(11):3299-3308.
11. de Oliveira F.S., Valete-Rosalino C.M., Schubach Ade O., Pacheco Rda S. kDNA minicircle signatures of Leishmania (Viannia) braziliensis in oral and nasal mucosa from mucosal leishmaniasis patients. Diagn Microbiol Infect Dis 2010, 66(4):361-365.
12. Declaration of Helsinki World Medical Association Available from:, [accessed on march 13]. http://www.wma.net/en/30publications/10policies/b3/.
13. Faber W.R., Oskam L., van Gool T., Kroon N.C., Knegt-Junk K.J., Hofwegen H., et al. Value of diagnostic techniques for cutaneous leishmaniasis. J Am Acad Dermatol 2003, 49(1):70-74.
14. Farias L.H., Rodrigues A.P., Silveira F.T., Seabra S.H., DaMatta R.A., Saraiva E.M., et al. Phosphatidylserine exposure and surface sugars in two Leishmania (Viannia) braziliensis strains involved in cutaneous and mucocutaneous leishmaniasis. J Infect Dis 2013, 207(3):537-543.
15. Figueroa R.A., Lozano L.E., Romero I.C., Cardona M.T., Prager M., Pacheco R., et al. Detection of Leishmania in unaffected mucosal tissues of patients with cutaneous leishmaniasis caused by Leishmania (Viannia) species. J Infect Dis 2009, 200(4):638-646.
16. Flahault A., Cadilhac M., Thomas G. Sample size calculation should be performed for design accuracy in diagnostic test studies. J Clin Epidemiol 2005, 58(8):859-862.
17. Goto H., Lauletta Lindoso J.A. Cutaneous and mucocutaneous leishmaniasis. Infect Dis Clin North Am 2012, 26(2):293-307.
18. Kline K., McCarthy J.S., Pearson M., Loukas A., Hotez P.J. Neglected tropical diseases of Oceania: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis 2013, 7(1):1-9. e1755.
19. Lessa H.A., Lessa M.M., Guimarães L.H., Lima C.M., Arruda S., Machado P.R., et al. A proposed new clinical staging system for patients with mucosal leishmaniasis. Trans R Soc Trop Med Hyg 2012, 106(6):376-381.
20. Lugassy J., Itin P., Ishida-Yamamoto A., Holland K., Huson S., Geiger D., et al. Naegeli-Franceschetti-Jadassohn syndrome and dermatopathia pigmentosa reticularis: two allelic ectodermal dysplasias caused by dominant mutations in KRT14. Am J Hum Genet 2006, 79(4):724-730.
21. Maretti-Mira A.C., de Pinho Rodrigues K.M., de Oliveira-Neto M.P., Pirmez C., Craft N. MMP-9 activity is induced by Leishmania braziliensis infection and correlates with mucosal leishmaniasis. Acta Trop 2011, 119(2-3):160-164.
22. Momeni Boroujeni A., Aminjavaheri M., Moshtaghian B., Momeni A., Momeni A.Z. Reevaluating leishmanin skin test as a marker for immunity against cutaneous leishmaniasis. Int J Dermatol 2013, 52(7):827-830.
23. Motta A.C., Lopes M.A., Ito F.A., Carlos-Bregni R., de Almeida O.P., Roselino A.M. Oral leishmaniasis: a clinicopathological study of 11 cases. Oral Dis 2007, 13(3):335-340.
24. Name R.Q., Borges K.T., Nogueira L.S.C., Sampaio J.H.D., Tauil P.L., Sampaio R.N.R. Clinical, epidemiological and therapeuthic study of 402 patients with American cutaneous leishmaniasis seen at University Hospital of Brasilia, DF, Brazil. An Bras Dermatol 2005, 80(3):249-254.
25. Oliveira J.G., Novais F.O., de Oliveira C.I., da Cruz Junior A.C., Campos L.F., da Rocha A.V., et al. Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis. Acta Trop 2005, 94(1):55-59.
26. Rahman S., Bari A. Laboratory profile in patients of cutaneous leishmaniasis from various regions of Pakistan. J Coll Physicians Surg Pak 2003, 13(6):313-316.
27. Reis Lde C., Brito M.E., Almeida E.L., Félix S.M., Medeiros A.C., Silva C.J., et al. Clinical, epidemiological and laboratory aspects of patients with American cutaneous leishmaniasis in the State of Pernambuco. Rev Soc Bras Med Trop 2008, 41(5):439-443.
28. Reithinger R., Dujardin J.C., Louzir H., Pirmez C., Alexander B., Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis 2007, 7(9):581-596.
29. Rodríguez-Cortés A., Ojeda A., Francino O., López-Fuertes L., Timón M., Alberola J. Leishmania infection: laboratory diagnosing in the absence of a "gold standard". Am J Trop Med Hyg 2010, 82(2):251-256.
30. Romero G.A., Vinitius De Farias Guerra M., Gomes Paes M., de Oliveira Macêdo V. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: clinical findings and diagnostic approach. Clin Infect Dis 2001, 32(9):1304-1312.
31. Sadeghian G., Ziaei H., Bidabadi L.S., Nilforoushzadeh M.A. Evaluation of leishmanin skin test reaction in different variants of cutaneous leishmaniasis. Indian J Dermatol 2013, 58(3):239.
32. Schubach A., Haddad F., Oliveira-Neto M.P., Degrave W., Pirmez C., Grimaldi G., et al. Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J Infect Dis 1998, 178(3):911-914.
33. Shirian S., Oryan A., Hatam G.R., Daneshbod K., Daneshbod Y. Molecular diagnosis and species identification of mucosal leishmaniasis in Iran and correlation with cytological findings. Acta Cytol 2012, 56(3):304-309.
34. Souza L.W., Souza S.V., Botelho A.C. Comparative analysis of the geographic distribution of the histopathological spectrum and Leishmania species of American cutaneous leishmaniasis in Brazil. An Bras Dermatol 2012, 87(3):369-374.
35. Sullivan K.M., Dean A., Soe M.M. OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Rep 2009, 124(3):471-474.
36. Szargiki R., Castro E.A., Luz E., Kowalthuk W., Machado A.M., Thomaz-Soccol V. Comparison of serological and parasitological methods for cutaneous leishmaniasis diagnosis in the state of Paraná, Brazil. Braz J Infect Dis 2009, 13(1):47-52.
37. Weinkopff T., Mariotto A., Simon G., Hauyon-La Torre Y., Auderset F., Schuster S., et al. Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection. Infect Immun 2013, 81(5):1575-1584.
38. Zeyrek F.Y., Korkmaz M., Ozbel Y. Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL is highly endemic. Clin Vaccine Immunol 2007, 14(11):1409-1415.